Literature DB >> 15634752

HIV prevention research and global inequality: steps towards improved standards of care.

K Shapiro1, S R Benatar.   

Abstract

Intensification of poverty and degradation of health infrastructure over recent decades in countries most affected by HIV/AIDS present formidable challenges to clinical research. This paper addresses the overall standard of health care (SOC) that should be provided to research participants in developing countries, rather than the narrow definition of SOC that has characterised the international debate on standards of health care. It argues that contributing to sustainable improvements in health by progressively ratcheting the standard of care upwards for research participants and their communities is an ethical obligation of those in resource-rich countries who sponsor and implement research in poorer ones.

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh:

Substances:

Year:  2005        PMID: 15634752      PMCID: PMC1734013          DOI: 10.1136/jme.2004.008102

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  19 in total

1.  Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.

Authors:  T Tucker; C Slack
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

Review 2.  Establishing ethical trials for treatment and prevention of AIDS in developing countries.

Authors:  Bernard Lo; Ronald Bayer
Journal:  BMJ       Date:  2003-08-09

3.  Medical researchers' ancillary clinical care responsibilities.

Authors:  Leah Belsky; Henry S Richardson
Journal:  BMJ       Date:  2004-06-19

4.  Ethical challenges in international HIV prevention research.

Authors:  Kathleen M MacQueen; Katharine Shapiro; Quarraisha Abdool Karim; Jeremy Sugarman
Journal:  Account Res       Date:  2004 Jan-Mar       Impact factor: 2.622

Review 5.  Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention.

Authors:  I de Zoysa; C J Elias; M E Bentley
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

Review 6.  Social inequalities and emerging infectious diseases.

Authors:  P Farmer
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 7.  Challenges for the development of female-controlled vaginal microbicides.

Authors:  C J Elias; L L Heise
Journal:  AIDS       Date:  1994-01       Impact factor: 4.177

8.  Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.

Authors:  Z Yuan; S Bowlin; D Einstadter; R D Cebul; A R Conners; A A Rimm
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

9.  Women's health and human rights in HIV prevention research.

Authors:  Daniel W Fitzgerald; Frieda M-T Behets
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

Authors:  H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

View more
  19 in total

Review 1.  Regulation of biomedical research in Africa.

Authors:  Sylvester C Chima
Journal:  BMJ       Date:  2006-04-08

2.  Solidarity: a (new) ethic for global health policy.

Authors:  Shawn H E Harmon
Journal:  Health Care Anal       Date:  2006-12

3.  Incidental findings and ancillary-care obligations.

Authors:  Henry S Richardson
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

4.  Human rights, cultural pluralism, and international health research.

Authors:  Patricia A Marshall
Journal:  Theor Med Bioeth       Date:  2005

Review 5.  Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.

Authors:  Pamela Andanda; Jane Wathuta
Journal:  Med Health Care Philos       Date:  2018-03

6.  Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Authors:  Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

7.  Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community.

Authors:  Catherine M Slack
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

8.  Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Authors:  Henry S Richardson
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

9.  Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.

Authors:  Bridget Haire; Morenike Oluwatoyin Folayan; Catherine Hankins; Jeremy Sugarman; Sheena McCormack; Gita Ramjee; Mitchell Warren
Journal:  Dev World Bioeth       Date:  2013-05-31       Impact factor: 2.294

10.  Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Charles Shagi; Shelley Lees; Katherine Shapiro; Joseph Masanja; Lawi Nikolau; Johari Kazimoto; Selephina Soteli; Claire Moffat; John Changalucha; Sheena McCormack; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2009-10-09       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.